Reuters logo
BRIEF-Sichuan Kelun Pharmaceutical unit gets approval for drug clinic trial
September 30, 2017 / 5:25 AM / 3 months ago

BRIEF-Sichuan Kelun Pharmaceutical unit gets approval for drug clinic trial

Sept 30 (Reuters) - Sichuan Kelun Pharmaceutical Co Ltd

* Says its unit received clinic trial approval for monoclonal antibody KL-A167 injection from China Food and Drug Administration

Source text in Chinese:goo.gl/4KRbmq

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below